Profile data is unavailable for this security.
About the company
Biolight Life Sciences Ltd, formerly Bio Light Israeli Life Sciences Investments Ltd, is an Israel-based company engaged, through its subsidiaries, in various fields of research and development of pharmaceuticals and medical products and devices. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The Company provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
- Revenue in ILS (TTM)118.00k
- Net income in ILS-26.02m
- Incorporated2005
- Employees4.00
- LocationBiolight Life Sciences LtdPark AtidimBinyan 7, Koma 2, T.D. 58172TEL AVIV-YAFO 58172IsraelISR
- Phone+972 732753400
- Fax+972 732753401
- Websitehttps://www.bio-light.co.il
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nextgen Biomed Ltd | 0.00 | -9.00m | 8.23m | 187.00 | -- | 0.7161 | -- | -- | -2.70 | -2.70 | 0.00 | 1.42 | 0.00 | -- | -- | -- | -51.61 | -32.00 | -54.98 | -35.24 | -- | -- | -- | -- | -- | -- | 0.1054 | -- | -- | -- | -236.16 | -- | -- | -- |
| Erech Finance Cahalacha Ltd | 282.00k | -25.29m | 8.43m | 18.00 | -- | 1.95 | -- | 29.89 | -9.97 | -9.97 | 0.1112 | 1.71 | 0.0061 | -- | 0.019 | -- | -53.84 | -15.68 | -132.10 | -31.24 | -659.22 | 66.49 | -8,841.49 | -133.65 | -- | -11.04 | 0.7966 | -- | -97.35 | -50.83 | -1.01 | -- | -- | -- |
| Human Xtensions Ltd | 4.95m | -36.64m | 8.91m | 50.00 | -- | 0.3413 | -- | 1.80 | -1.37 | -1.37 | 0.185 | 0.9757 | 0.0922 | 0.4634 | 2.21 | 99,000.00 | -68.25 | -49.34 | -77.27 | -55.69 | 51.66 | 49.34 | -740.10 | -485.43 | 4.75 | -- | 0.0608 | -- | 56.00 | -- | 17.84 | -- | -19.95 | -- |
| Sonovia Ltd | 0.00 | -27.00m | 10.99m | 44.00 | -- | 0.3367 | -- | -- | -1.67 | -1.50 | 0.00 | 1.98 | 0.00 | -- | -- | 0.00 | -55.93 | -- | -62.66 | -- | -- | -- | -- | -- | -- | -13.62 | 0.0054 | -- | -- | -- | -187.75 | -- | 77.26 | -- |
| BioLight Life Sciences Ltd | 118.00k | -26.02m | 20.76m | 4.00 | -- | 0.6972 | -- | 175.93 | -5.60 | -5.60 | 0.0255 | 6.39 | 0.0026 | -- | 0.2903 | 29,500.00 | -60.77 | -20.22 | -65.01 | -21.13 | -- | -- | -23,294.07 | -12,746.09 | -- | -0.6326 | 0.003 | -- | 87.30 | -49.76 | -231.59 | -- | 92.16 | -- |
| Elbit Medical Technologies Ltd | 1.29m | -65.97m | 20.85m | 232.00 | -- | 0.7794 | -- | 16.16 | -0.7351 | -0.7351 | 0.0147 | 0.295 | 0.0211 | -- | 38.67 | -- | -108.02 | 37.04 | -110.43 | 38.19 | -- | -- | -5,113.22 | 41.14 | -- | -0.011 | 0.00 | -- | 314.29 | -55.19 | -248.15 | -- | -- | -- |
| Erika B-Cure Laser Ltd | 29.88m | -19.22m | 29.27m | -- | -- | 1.23 | -- | 0.9795 | -0.185 | -0.185 | 0.2876 | 0.2278 | 0.5184 | 0.3945 | 4.08 | -- | -33.34 | -- | -49.63 | -- | 76.95 | 87.63 | -64.32 | -14.48 | 0.8936 | -- | 0.1726 | -- | -40.62 | -3.40 | 40.97 | -- | -19.27 | -- |
| Allmed Solutions Ltd | 0.00 | 1.42m | 31.14m | 19.00 | 17.83 | 0.658 | 16.40 | -- | 0.0182 | 0.0182 | 0.00 | 0.4924 | 0.00 | -- | -- | 0.00 | 2.43 | 1.43 | 2.68 | 1.59 | -- | 50.43 | -- | 15.58 | -- | -- | 0.0154 | -- | -- | -- | 111.71 | -- | -10.48 | -- |
| Endymed Ltd | 84.46m | 2.05m | 40.53m | 46.00 | 19.30 | 0.7158 | 10.94 | 0.48 | 0.1526 | 0.1526 | 6.20 | 4.11 | 1.13 | 2.46 | 18.63 | 1,835,987.00 | 2.75 | 10.38 | 3.38 | 13.32 | 51.20 | 51.92 | 2.43 | 8.91 | 3.02 | -- | 0.0771 | -- | 6.77 | 4.30 | -34.94 | -22.83 | -15.24 | -- |
| Epitomee Medical Ltd | 37.08m | -21.07m | 101.00m | 42.00 | -- | 0.7827 | -- | 2.72 | -0.7116 | -0.7116 | 1.25 | 4.34 | 0.2095 | -- | 35.21 | 882,761.90 | -11.90 | -- | -12.44 | -- | -- | -- | -56.82 | -- | -- | -- | 0.1021 | -- | -- | -- | 63.08 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ayalon Financial Solutions (2004) Ltd.as of 28 Dec 2023 | 64.00k | 1.37% |
| Psagot Mutual Funds Ltd.as of 31 Dec 2023 | 4.21k | 0.09% |
| Ayalon Mutual Funds Ltd.as of 31 Dec 2023 | 1.50k | 0.03% |
